Test my supply
67%
Finnrick rating
#222 of 301 ranked vendors
61 of 87 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Peptide Partners' purity-focus record is strongest in Retatrutide and Ipamorelin, with Tirzepatide mostly passing despite an underfill caveat. Weakness clusters in TB-500, CJC-1295, Tesamorelin and BPC-157, where purity misses and large fill swings make the catalog dispersed; recent, batch-documented volume shows rebounds but continued volatility.

methodology →
vendor intelligence report
Vendor Intelligence Report: Peptide Partners

Policies name Pirsek Technologies and Wyoming law, but registry searches leave the entity chain partly open. The full briefing maps Zak David’s public operator trail, the Shopify-to-WooCommerce migration, referral-code network, Trustpilot removal, and COA/lab controls.

27 pages7 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$4.85
92%
25
2
GHK-Cu
$0.75
91%
4
3
Ipamorelin
$3.74
85%
8
4
Tirzepatide
$2.31
80%
7
5
BPC-157
$5.30
55%
10
6
Tesamorelin
$4.95
47%
12
7
CJC-1295
$4.50
36%
9
8
TB-500
$4.90
33%
13
Contact channels
Vendor policies

Batch identification policy

All vial labels have a Batch Id that can be reconciled against the various COAs for Purity/Assay, Endotoxin, Heavy Metals, or Sterility testing at

Sample authentication guidance

Our 3mL vials have a 1.25" x 0.75" white, BOPP label. At the top of the label is the full logo with the 'P Vial' symbol on the left, followed Peptide Partners, and underneath it says "CONNECTING THE GLOBAL RESEARCH COMMUNITY." Underneath the logo is a line identifying the molecule and weight. Underneath that is the word 'Batch' followed by an identification code. At the bottom of the label it reads "Research Use Only"

Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%10 Feb 2026: 56%10 Feb 2026: 57%10 Feb 2026: 57%10 Feb 2026: 58%11 Feb 2026: 59%11 Feb 2026: 58%11 Feb 2026: 59%11 Feb 2026: 59%15 Feb 2026: 60%15 Feb 2026: 60%18 Feb 2026: 60%18 Feb 2026: 60%18 Feb 2026: 59%18 Feb 2026: 59%20 Feb 2026: 60%22 Feb 2026: 60%1 Mar 2026: 60%2 Mar 2026: 60%2 Mar 2026: 61%3 Mar 2026: 61%4 Mar 2026: 61%4 Mar 2026: 61%23 Apr 2026: 64%23 Apr 2026: 65%28 Apr 2026: 64%28 Apr 2026: 65%8 May 2026: 65%12 Jun 2026: 65%16 Jun 2026: 65%22 Jun 2026: 65%14 Jul 2026: 65%14 Jul 2026: 65%20 Jul 2026: 65%4 Aug 2026: 65%5 Aug 2026: 65%5 Aug 2026: 65%5 Aug 2026: 66%5 Aug 2026: 66%5 Aug 2026: 66%5 Aug 2026: 67%10 Aug 2026: current 67%56%64%67%Feb 26Aug 26
Test my supply
Peptide Partners test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
5 Aug 2026Pass
Retatrutide
lab nameView COA
5 Aug 2026Pass
Ipamorelin
lab nameView COA
5 Aug 2026Fail
Tesamorelin
lab nameView COA
5 Aug 2026Pass
TB-500
lab nameView COA
5 Aug 2026Pass
GHK-Cu
lab nameView COA
5 Aug 2026Pass
BPC-157
lab nameView COA
4 Aug 2026Pass
Retatrutide
lab nameView COA
20 Jul 2026Fail
TB-500 (Thymosin Beta-4)
lab nameView COA
14 Jul 2026Pass
GHK-Cu
lab nameView COA
14 Jul 2026Pass
GHK-Cu
lab nameView COA
1-10 of 88

About Peptide Partners test results from Finnrick

Peptide Partners is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 88 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Peptide Partners peptides in this dataset are Retatrutide (25 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 88 recent tests.

Corrections
No corrections.
Test my supply